Olympus Co. (OTCMKTS:OLYMY) Short Interest Update

Olympus Co. (OTCMKTS:OLYMY) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 13 shares, a decrease of 99.9% from the June 15th total of 11,090 shares. Based on an average daily volume of 160,531 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group lowered shares of Olympus from a “buy” rating to a “neutral” rating in a research note on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Olympus has an average rating of “Hold”.

Olympus Trading Up 1.2%

Shares of OTCMKTS:OLYMY traded up $0.13 during trading hours on Friday, reaching $10.87. The stock had a trading volume of 31,621 shares, compared to its average volume of 108,660. Olympus has a 1 year low of $8.08 and a 1 year high of $13.73. The firm’s 50 day moving average is $10.82 and its 200-day moving average is $10.76.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.